T Cell News and Research

Latest T Cell News and Research

Researchers identify new virus alert signal that triggers the human immune system

Researchers from Aarhus University have now located the place in the human body where the earliest virus alert signal triggers the human immune system. They have also discovered a new alarm signal, which is activated at the very first sign of a virus attack.

23 Jun 2012

Scientists identify novel animal reservoir for tick-borne diseases

A team of scientists at Washington University in St. Louis has been keeping a wary eye on emerging tick-borne diseases in Missouri for the past dozen years, and they have just nailed down another part of the story.

23 Jun 2012

Plant compounds from South African daffodils show promise for depression

Scientists at the University of Copenhagen have previously documented that substances from the South African plant species Crinum and Cyrtanthus - akin to snowdrops and daffodils - have an effect on the mechanisms in the brain that are involved in depression.

23 Jun 2012

EC grants marketing authorization for AMAG's ferumoxytol to treat IDA

AMAG Pharmaceuticals, Inc. today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).

23 Jun 2012

IASLC to host 5th Latin American Conference on Lung Cancer in Brazil

The International Association for the Study of Lung Cancer (IASLC) is hosting the 5th Latin American Conference on Lung Cancer July 25 to 27 in Rio de Janeiro, Brazil. Nearly 1,000 medical professionals will gather to discuss the latest lung cancer research and treatment.

23 Jun 2012

Researchers uncover why ointment and photodynamic therapy cause pain in skin cancer patients

Apply the ointment, light on, light off - that's how easy it is to cure various forms of non-melanoma skin cancer. However, the majority of patients suffer severe pain during the so-termed photodynamic therapy.

23 Jun 2012

International conference showcases breadth of research possible with zebrafish

It's clear where the black-and-white striped zebrafish got its name, but less obvious at first glance is what zebrafish has to do with biomedical research. Amazingly, it has biological similarities to humans, which are making this small freshwater fish an increasingly popular model organism for studying vertebrate development, genetics, physiology, and mechanisms of disease.

23 Jun 2012

First study to demonstrate that microbes are specific to their host species

Gut bacteria's key role in immunity is tuned to the host species, researchers have found, suggesting that the superabundant microbes lining our digestive tract evolved with us-a tantalizing clue in the mysterious recent spike in human autoimmune disorders.

23 Jun 2012

Wake Forest Baptist researchers achieve early milestone in lab-engineered kidney project

Regenerative medicine researchers at Wake Forest Baptist Medical Center have reached an early milestone in a long-term project that aims to build replacement kidneys in the lab to help solve the shortage of donor organs.

23 Jun 2012

Patients with psoriasis at increased risk for developing diabetes

Study findings suggest that psoriasis is an independent risk factor for the development of Type 2 diabetes.

22 Jun 2012

Skin patch treatment kills common skin cancer

A skin patch treatment for a common type of skin cancer called basal cell carcinoma effectively destroys facial tumors in most patients without the need for surgery or major radiation, researchers report.

22 Jun 2012

Smoking increases skin cancer risk

Individuals who smoke may be increasing their risk for developing a type of skin cancer called squamous cell carcinoma, a review of published studies suggests.

22 Jun 2012

Parents play a major role in children's TV time

Researchers at Oregon State University have confirmed what we knew all along - children in this country are increasingly sedentary, spending too much time sitting and looking at electronic screens.

22 Jun 2012

A potential drug target for NK/T-cell lymphoma

A discovery by Van Andel Institute researchers has identified a potential drug target for NK/T-cell lymphoma, a type of cancer responsible for claiming the life of a close friend and fellow researcher.

22 Jun 2012

Novel small-molecule-inhibiting drug stops spread of breast cancer cells

Scientists have developed a small-molecule-inhibiting drug that in early laboratory cell tests stopped breast cancer cells from spreading and also promoted the growth of early nerve cells called neurites.

22 Jun 2012

Researchers identify genes that cooperate in development of medulloblastoma

St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project lifts lid on the most aggressive subtype of medulloblastoma and finds genes that cooperate in tumor development.

22 Jun 2012

Grb2 switch controls normal signaling through fibroblast growth factor receptor

Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell.

22 Jun 2012

Evolutionary principles of natural selection may be applied to successfully manage cancer

According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which nature selects certain physical attributes, or phenotypes, to pass on to offspring to better "fit" the organism to the environment.

22 Jun 2012

New methods to track stem cells

Researchers at the University of Liverpool have developed new methods to track stem cells and further understanding of what happens to them after they have been in the body for a significant period of time.

22 Jun 2012

Faulty conclusions due to contamination, misidentification and redundancy in widely available cell lines

Modern cancer therapies start in cells - researchers compare cancer samples to healthy cells to discover how cancer is genetically different, and use cell lines to test promising new drugs. However, a University of Colorado Cancer Center study published this week in the journal Gynecologic Oncology shows that due to a high rate of contamination, misidentification and redundancy in widely available cell lines, researchers may be drawing faulty conclusions.

22 Jun 2012